THOUGHT LEADERSHIP

Quick Take on the Fourth Plenum: The Party Will Save the Day

Quick Take on the Fourth Plenum: The Party Will Save the Day

Plenums serve as core legislative meetings of each Party Congress, providing Party officials a platform to set China’s key policy priorities. Interpreting the Fourth Plenum – which concluded in Beijing yesterday – is essential to protecting business interests and anticipating new regulatory trends. The eagerly awaited meeting stressed the need…

China’s Foreign Investment Law Takes Shape

China’s Foreign Investment Law Takes Shape

The Foreign Investment Law (FIL) stands to redefine the terms and technical requirements for foreign enterprises investing in China. It serves as the policymakers’ vision for further market opening and streamlined bureaucratic procedures, clarifying standards for foreign investment while maintaining unified government control. This legislation aims to level the playing field…

Trade War and the Search for Safe Havens: Rethinking RCEP?

Trade War and the Search for Safe Havens: Rethinking RCEP?

Trade War and the Search for Safe Havens: Rethinking RCEP? The Regional Comprehensive Economic Partnership, or RCEP – which would see 10 members of ASEAN and their six FTA partners form a free trade zone, notably including China, Japan and India – has had a low profile until now. Initiated…

Working together in the age of turbulence

Working together in the age of turbulence

By Robert MAGYAR, Senior Executive Director,Jiawen MA, Associate Director – Public Affairs, and Leyla JIANG, Associate Director – Healthcare Turbulence has replaced constant change. Technological, economic, and political disruptions of the past three decades created an environment, where managing businesses against a backdrop of relentless structural transformation was the norm. Corporations and policymakers…

Trade War and the Search for Safe Havens: Rethinking RCEP?

Trade War and the Search for Safe Havens: Rethinking RCEP?

The Regional Comprehensive Economic Partnership, or RCEP – which would see 10 members of ASEAN and their six FTA partners form a free trade zone, notably including China, Japan and India – has had a low profile until now. Initiated in 2012, RCEP is often dismissed by western commentators. But…

China Healthcare Outlook – 2019 Issue 3

China Healthcare Outlook – 2019 Issue 3

Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include: State Council releases 2019 Work Tasks to Deepen Healthcare Reform Center for Drug Evaluation releases the first real-world evidence application policy in China for public comment National Health Commission initiates pilot programs to develop hospital…

China Healthcare Outlook – 2019 Issue 2

China Healthcare Outlook – 2019 Issue 2

Recent policies reflect China’s goal of promoting patients’ ac- cess to innovative drugs. Note- worthy policy items include: NMPA issued China Drug Regulatory Scientific Action Plan NHSA released Work Plan for the 2019 Adjustment to the National Reimbursement Drug List (NRDL) NHSA and MoF jointly released Notice on Key Tasks…

FAST TAKE on China: US-China friction and the challenges of contradictory compliance needs

FAST TAKE on China: US-China friction and the challenges of contradictory compliance needs

North Head’s Director of Public Affairs, Mike Dennison examines the GR challenges posed by recent changes in US-China relations The recent souring of US-China relations that started with the breakdown of talks in early May will potentially have long-term implications for international companies operating in and with China. Government relations professionals need to develop…

China Healthcare Outlook-2019 Issue 1

China Healthcare Outlook-2019 Issue 1

Recent policies reflect China’s goal of promoting patients’ accessto innovative drugs. Noteworthy policy items include: NHSA released Work Plan for the 2019 Adjustment to the National Reimbursement Drug List for public comment NHSA released Opinions on the Implementation of National Centralized Procurement and Supporting Medical Insurance Measures NHC Published Measures…

CHINA HEALTHCARE OUTLOOK – 2018 Issue 6

CHINA HEALTHCARE OUTLOOK – 2018 Issue 6

RECENT HEALTHCARE DEVELOPMENTS Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include: The 2018 version of the Essential Drug List (EDL) was approved National Reimbursement Drug List (NRDL) Negotiation Results Released NMPA released List of Medical Devices Exempted from Clinical Trials Zhang Mao…

CHINA HEALTHCARE OUTLOOK – 2018 Issue 5

CHINA HEALTHCARE OUTLOOK – 2018 Issue 5

RECENT HEALTHCARE DEVELOPMENTS Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include: State Council released the Plan for Reforming the Division of Fiscal Administration Power and Expenditure Responsibilities between the Central and Local Level in the Area of Healthcare China’s Politburo Held a…

CHINA HEALTHCARE OUTLOOK-2018 Issue 4

CHINA HEALTHCARE OUTLOOK-2018 Issue 4

Recent policies reaffirm China’s goal to further enhance patients’ access and signal certain reform directions in the future. Noteworthy policy items include: Premier Li Keqiang announced three tasks to promote patient access to anti-cancer drugs and reduce drug prices NDRC and MOFCOM released Negative List 2018 Version SDA released 2017…

CHINA HEALTHCARE OUTLOOK – 2018 Issue 3

CHINA HEALTHCARE OUTLOOK – 2018 Issue 3

Recent policies provide detailed instruction to promote the implementation of preferential policies of high-value drugs. Noteworthy policy items include: President Xi emphasized promoting a Comprehensive Regulatory System of Healthcare at the second meeting of the Central Leading Committee for Comprehensively Deepening Reform State Council released Plans for Deepening Reforms and…

China Healthcare Outlook – 2018 Issue 1

China Healthcare Outlook – 2018 Issue 1

Recent policy developments show Chinese government’s efforts in encouraging pharmaceutical innovation, improving the drug review and approval, and promoting the development of healthcare professionals. Recent noteworthy policy items include: CFDA and MOST jointly released Guiding Opinions on Strengthening and Promoting Technological Innovation in the Food and Drug Sector The China…

Robert Magyar publishes chapter on nature, challenges of PA in China

Robert Magyar publishes chapter on nature, challenges of PA in China

In June, North Head Executive Director Robert Magyar’s work was published in Public Affairs: A Global Perspective, a new book by the UK’s Urbane Publications. His chapter, titled “Public Affairs in China: At a Crossroads?” deals with the complexities of government relations work in a country where the overlapping activities…

Two Sessions 2018: China’s ‘New Era’ Takes Shape

Two Sessions 2018: China’s ‘New Era’ Takes Shape

Each March, China convenes its annual “Two Sessions” – the National People’s Congress (NPC), China’s legislature, and the Chinese People’s Political Consultative Conference (CPPCC), a political advisory body. During Two Sessions, constitutional amendments, government restructuring, and senior personnel appointments are raised, which will further reshape the regulatory environment. North Head…

China Healthcare Outlook – 2018 Issue 2

China Healthcare Outlook – 2018 Issue 2

These macro-level policy developments indicate the Chinese government’s decision to further open the economy, and to place increasing emphasis on improving people’s livelihood. Noteworthy policy items include:  President Xi Jinping delivered a keynote speech at the opening ceremony of the Boao Forum for Asia (BFA) Annual Conference 2018 MOF released…

Environment Newsletter – Vol. 4, Ed. 4

Environment Newsletter – Vol. 4, Ed. 4

In June-July, the central government revised legislation to strengthen control of water pollutants and appointed a new Minister of Environmental Protection. Major updates include: Revisions to the Water Pollution Prevention and Treatment Law will increase monitoring of pollutant emissions and increase public awareness of and governance of water quality at…

China Healthcare Outlook – 2017 Issue 5

China Healthcare Outlook – 2017 Issue 5

Recent policy developments show the government’s concern over controlling medical expenditure, enhancing drug safety, and increasing international participation. Recent noteworthy policy items include: * NHFPC released 2016 China Health and Family Planning Development Report * State Council released Measures to Promote Foreign Investment * CFDA released the Circular on the…

Volume 4 Edition 1 | Fallout from Reform

Volume 4 Edition 1 | Fallout from Reform

This issue reviews China’s reform program arising from the October 2013 Third Plenum and approved at the 2014 National People’s Congress. In particular, this edition looks at the effects of these reforms on companies and governments. The latest issue in English can be downloaded Here.

Volume 4 Edition 2 | Adapting to the "New Normal" Environment

Volume 4 Edition 2 | Adapting to the "New Normal" Environment

This issue Adapting to the “new normal” environment reviews the rapid changes in China with respect to environmental public policy and regulation. Environmental degradation has become an issue of political sensitivity and a drag on China’s development and economic reform. The latest issue in English can be downloaded Here.